<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Use of cephalosporins in patients with positive skin tests to penicillin</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Use of cephalosporins in patients with positive skin tests to penicillin</h1>
<div class="graphic"><div class="figure"><div class="ttl">Use of cephalosporins in patients with positive skin tests to penicillin</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1">Study</td> <td class="subtitle1">Number of patients</td> <td class="subtitle1">Number of reactions (%)</td> <td class="subtitle1">Cephalosporin skin testing</td> <td class="subtitle1">Comment</td> </tr> <tr> <td>Girard (1968)<sup>[1]</sup></td> <td class="centered">23</td> <td class="centered">2 (8.7)</td> <td class="centered">No</td> <td>Both reactions to cephaloridine</td> </tr> <tr> <td>Assem (1974)<sup>[2]</sup></td> <td class="centered">3</td> <td class="centered">3 (100)</td> <td class="centered">No</td> <td>All reactions to cephaloridine</td> </tr> <tr> <td>Warrington (1978)<sup>[3]</sup></td> <td class="centered">3</td> <td class="centered">0</td> <td class="centered">Yes</td> <td> </td> </tr> <tr> <td>Solley (1982)<sup>[4]</sup></td> <td class="centered">27</td> <td class="centered">0</td> <td class="centered">No</td> <td> </td> </tr> <tr> <td>Saxon (1987)<sup>[5]</sup></td> <td class="centered">62</td> <td class="centered">1 (1.6)</td> <td class="centered">No</td> <td>Cephalosporin not noted</td> </tr> <tr> <td>Blanca (1989)<sup>[6]</sup></td> <td class="centered">16</td> <td class="centered">2 (12.5)</td> <td class="centered">No</td> <td>Both reactions to cefamandole</td> </tr> <tr> <td>Shepherd (1993)<sup>[7]</sup></td> <td class="centered">9</td> <td class="centered">0</td> <td class="centered">No</td> <td> </td> </tr> <tr> <td>Audicana (1994)<sup>[8]</sup></td> <td class="centered">12</td> <td class="centered">0</td> <td class="centered">Yes</td> <td> </td> </tr> <tr> <td>Pichichero (1998)<sup>[9]</sup></td> <td class="centered">39</td> <td class="centered">2 (5.1)</td> <td class="centered">No</td> <td>Reaction to cefaclor and ?</td> </tr> <tr> <td>Novalbos (2001)<sup>[10]</sup></td> <td class="centered">23</td> <td class="centered">0</td> <td class="centered">Yes</td> <td> </td> </tr> <tr> <td>Macy (2002)<sup>[11]</sup></td> <td class="centered">42</td> <td class="centered">1 (2.4)</td> <td class="centered">No</td> <td>Reaction to cefixime</td> </tr> <tr> <td>Romano (2004)<sup>[12]</sup></td> <td class="centered">75</td> <td class="centered">0</td> <td class="centered">Yes</td> <td> </td> </tr> <tr> <td>Greenberger (2005)<sup>[13]</sup></td> <td class="centered">6</td> <td class="centered">0</td> <td class="centered">No</td> <td> </td> </tr> <tr> <td>Park (2010)<sup>[14]</sup></td> <td class="centered">85</td> <td class="centered">2 (2.4)</td> <td class="centered">No</td> <td>Reactions to cefazolin, cephalexin</td> </tr> <tr class="divider_bottom"> <td>Ahmed (2012)<sup>[15]</sup></td> <td class="centered">21 </td> <td class="centered">0 </td> <td class="centered">No </td> <td> </td> </tr> <tr> <td><strong>Total</strong></td> <td class="centered"><strong>446</strong></td> <td class="centered"><strong>13 (2.9)</strong></td> <td class="centered"><strong> </strong></td> <td><strong> </strong></td> </tr> </tbody></table></div><div class="graphic_lgnd">Summary of penicillin skin test-positive patients challenged with cephalosporins, excluding patients selectively allergic to amoxicillin or ampicillin (skin test-positive to an aminopenicillin, but negative to penicillin G-derived major and minor determinants).</div><div class="graphic_reference">References:<br/><ol>
<li>Girard JP. Common antigenic determinants of penicillin G, ampicillin and the cephalosporins demonstrated in men. Int Arch Allergy Appl Immunol 1968; 33:428. </li>
<li>Assem ES, Vickers MR. Tests for penicillin allergy in man. II. The immunological cross-reaction between penicillins and cephalosporins. Immunology 1974; 27:255. </li>
<li>Warrington RJ, Simons FE, Ho HW, Gorski BA. Diagnosis of penicillin allergy by skin testing: the Manitoba experience. Can Med Assoc J 1978; 118:787. </li>
<li>Solley, GO, Gleich GJ, Van Dellen RG. Penicillin allergy: Clinical experience with a battery of skin-test reagents. J Allergy Clin Immunol 1982; 69:238. </li>
<li>Saxon A, Beall GN, Rohr AS, Adelman DC. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 1987; 107:204. </li>
<li>Blanca M, Fernandez J, Miranda A, et al. Cross-reactivity between penicillins and cephalosporins: Clinical and immunologic studies. J Allergy Clin Immunol 1989; 83:381. </li>
<li>Shepherd GM, Burton DA. Administration of cephalosporin antibiotics to patients with a history of penicillin allergy. J Allergy Clin Immunol 1993; 91:262 </li>
<li>Audicana M, Bernaola G, Urrutia I, et al. Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross-reactivity with cephalosporin. Allergy 1994; 49:108. </li>
<li>Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr 1998; 132:137. </li>
<li>Novalbos A, Sastre J, Cuesta J, et al. Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins. Clin Exp Allergy 2001; 31:438. </li>
<li>Macy E, Burchette RJ. Oral antibiotic adverse reactions after penicillin skin testing: multi-year follow-up. Allergy 2002; 57:1151. </li>
<li>Romano A, Guéant-Rodriguez RM, Viola M, et al. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med 2004; 141:16. </li>
<li>Greenberger PA, Klemens JC. Utility of penicillin major and minor determinants for identification of allergic reactions to cephalosporins. J Allergy Clin Immunol 2005; 115:S182 </li>
<li>Park MA, Koch CA, Klemawesch P, et al. Increased adverse drug reactions to cephalosporins in penicillin allergy patients with positive penicillin skin test. Int Arch Allergy Immunol 2010; 153:268. </li>
<li>Ahmed KA, Fox SJ, Frigas E, Park MA. Clinical outcome in the use of cephalosporins in pediatric patients with a history of penicillin allergy. Int Arch Allergy Immunol 2012; 158:405.</li></ol></div><div id="graphicVersion">Graphic 57958 Version 9.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
